| DETAILS: | Health, (Edit) |
|---|---|
| Address: | suite 3 level 4/828 Pacific Hwy, Gordon NSW 2072, Australia |
| Postal code: | 2072 |
| Phone: | (02) 9144 2223 |
| Website: | http://www.noxopharm.com/ |
Noxopharm Limited Level 20, Tower A, The Zenith 821 Pacific Highway CHATSWOOD NSW 2067 or PO Box 292, Gordon 2072. NSW AUSTRALIA Telephone: + 61 2 9144 2223. ABN 50 608 966 123 . Contact us. Email Shareholder enquiries: info@noxopharm.com Patient enquiries: medical.information@noxopharm.com My shareholding:
https://www.noxopharm.com/Noxopharm Limited Tower A, The Zenith Level 20 821 Pacific Highway Chatswood, NSW 2067 Australia 61 2 9144 2223 https://www.noxopharm.com Sector(s) : Healthcare Industry : Biotechnology Full Time ...
https://finance.yahoo.com/quote/NOX.AX/profile/Noxopharm is an Australian publicly-listed (ASX: NOX) clinical stage drug development company. The clinical stage drug candidate is Veyonda® (previously known as NOX-66). Veyonda® is a first-in-class, dual-acting cytotoxic and immuno-oncology drug candidate designed to enhance the effectiveness and safety of both chemotherapy and radiotherapy
http://investor.noxopharm.com/site/about-us+61 2 9144 2223. Turramurra, New South Wales Office. PO Box 828, Turramurra, New South Wales, 2074, Australia +61 2 9144 2223. Noxopharm Profile and History . Noxopharm Limited (ASX:NOX) is an Australian clinical-stage drug development company focused on the treatment of cancer and cytokine release syndrome (septic shock). ...
https://www.datanyze.com/companies/noxopharm/397452944Noxopharm is an Australian publicly-listed (ASX: NOX) clinical stage drug development company. The clinical stage drug candidate is Veyonda® (previously known as NOX-66). Veyonda® is a first-in-class, dual-acting cytotoxic and immuno-oncology drug candidate designed to enhance the effectiveness and safety of both chemotherapy and radiotherapy
https://investor.noxopharm.com/site/about-us/privacy-policyNoxopharm Limited (NOX) is a clinical-stage Australian drug development company with offices in Sydney and New York. ... 02 9144 2223 . info@noxopharm.com. www.noxopharm.com. Lists and Charts. Share Price. Closing price for the last 90 trading days. View Full Chart.
https://www.businessnews.com.au/Company/NoxopharmSee all company news (17.May.2022) European Patent to Be Granted for Cholesterol-Lowering Drug (29.Mar.2022) FDA Grants Orphan Drug Designation to Noxopharm for Sarcoma Treatment (08.Mar.2022) Sarcoma Trial for New Cancer Treatment Begins at City of Hope in Los Angeles
https://www.cmocro.com/company/Noxopharm+Ltd./index.htmlView Olivier Laczka's business profile as Group Chief Scientific Officer at Noxopharm Limited. Find Olivier's email address, mobile number, work history, and more.
https://www.apollo.io/people/Olivier/Laczka/5ff7e92abdb7eb00017c02a3Noxopharm Limited (ASX:NOX) Share Price Today, Stock News and Charts, fundamentals and dividend information, Trends, Announcements and Unique Analysis on Kalkine Media.
https://beta.kalkinemedia.com/au/companies/healthcare/nox-noxopharm-limitedView Mark Waring's business profile as Senior VP US Operations at Noxopharm Limited. Find Mark's email address, mobile number, work history, and more.
https://www.apollo.io/people/Mark/Waring/54a235c574686935be852016The phone number for Noxopharm Limited is (02) 9144 2223.
Noxopharm Limited is located at suite 3 level 4/828 Pacific Hwy, Gordon NSW 2072, Australia
The website (URL) for Noxopharm Limited is: http://www.noxopharm.com/